- Management believes uplisting has the potential to provide shareholders with improved liquidity
- Requires NRx Pharmaceuticals to meet certain listing requirements
- Company has advised NASDAQ that current shares outstanding is 15.7 million
Monday, January 13, 2025
NRx Pharma Applies to Uplist to the NASDAQ Global Market from the NASDAQ Capital Market
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.